SCHEMBL3661788

SCHEMBL3661788

CCCOc1cc(O)c(C(=O)OC)cc1Cl

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.43
THRB P10828 2/20 0.42
THRA P10827 1/20 0.42
LMNA P02545 1/20 0.42
CA12 O43570 2/20 0.41
CA1 P00915 2/20 0.41
CA2 P00918 2/20 0.41
CA7 P43166 2/20 0.41
CA9 Q16790 2/20 0.41
CA14 Q9ULX7 2/20 0.41
PDK2 Q15119 1/20 0.41
PDK4 Q16654 1/20 0.41
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
DPP4 P27487 1/20 0.40
CSNK2A1 P68400 2/20 0.40
S1PR4 O95977 1/20 0.40
MAPT P10636 1/20 0.40
HMGCR P04035 2/20 0.40
FABP4 P15090 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21662627 0.87 MAPT (0.43) GAATHRBTHRALMNACA12
SCHEMBL16482815 0.82 THRB (0.50) GAATHRBTHRALMNAMAPT
SCHEMBL2793251 0.81 GAA (0.58) GAALMNACA12CA1CA2
SCHEMBL21662632 0.79 SCN9A (0.49)
SCHEMBL2797704 0.78 HPGD (0.56) LMNANPC1RAB9A
SCHEMBL7415528 0.77 CA12 (0.55) GAALMNACA12CA1CA2
SCHEMBL13336372 0.77 HTT (0.46) CA12CA1CA2CA7CA9
SCHEMBL1792176 0.76 ALDH1A1 (0.52) GAALMNANPC1RAB9AMAPT
SCHEMBL3661787 0.76 HTT (0.46) GAALMNACA12CA1CA2
SCHEMBL30463099 0.76 CA12 (0.53) GAALMNACA12CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101855224-A Equilibrative nucleoside transporter ENT 1 inhibitors JANSSEN PHARMACEUTICA NV 2010-10-06 CN disclosed
EP-2209790-A2 EQUILIBRATIVE NUCLEOSIDE TRANSPORTER ENT1 INHIBITORS Janssen Pharmaceutica, N.V. (BE) 2010-07-28 EP disclosed
WO-2009062990-A2 EQUILIBRATIVE NUCLEOSIDE TRANSPORTER ENT1 INHIBITORS JANSSEN PHARMACEUTICA NV (BE) 2009-05-22 WO disclosed